Date: Nov 25, 2013 Source: (
click here to go to the source)
COLUMBIA, MD — Diagnostic Biochips, Inc reported today in a filing with the U.S. Securities and Exchange Commission it had raised $150K in new funding. Companies file this special form with the U.S. Securities and Exchange Commission in the majority of cases when closing new funding.
First Sale Amount Sold Amount Offered
Dec 7, 2013 $150K $150K
Diagnostic Biochips, Inc did not disclose revenue figures according to the SEC Filing detailing the transaction. The type of investment being offered was listed as equity (opposed to debt, warrants, or other types of investment options). Diagnostic Biochips, Inc noted they began raising the money on December 7, 2013. As of today, the entire $150K offering has been sold to private investors, no remaining investment is being sought at this time.
Digging into Diagnostic Biochips, Inc's fundraising history, this is the first SEC filing we've seen from Diagnostic Biochips, Inc. This doesn't mean they haven't raised money in the past, this is the first time Diagnostic Biochips, Inc has raised money and filed a special form with the SEC.
Individuals listed in this offering by Diagnostic Biochips, Inc include: Robert Seaton Collins (Executive Officer, Director) of Columbia, Md ; Brian Glenn Jamieson (Executive Officer, Director) of Columbia, Md
